Elpiscience (suzhou) Biopharma, Ltd.

This Phase 2 trial is testing a drug called ES014 in 50 adults with desmoid tumors, a type of non-cancerous but often painful growth. The drug is given as an IV infusion every two weeks. The main goal is to see if the tumors shrink, while also checking safety and quality of life.

This study tests whether adding an experimental drug (ES102) to an approved immunotherapy (toripalimab) can shrink tumors in people with advanced non-small cell lung cancer that has not responded to prior treatment. About 40 adults aged 18-75 will receive the combination and be m…